Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteprivacy & cookiesCuration ProcessContact
logos LINCs Logo Mt Sinai Logo NIH Logo NCI Logo
Protein Page:
ITGAV (human)
p Phosphorylation
ac Acetylation
me Methylation
m1 Mono-methylation
m2 Di-methylation
m3 Tri-methylation
ub Ubiquitylation
sm Sumoylation
ne Neddylation
gl O-GlcNAc
ga O-GalNAc
pa Palmitoylation
ad Adenylation
sn S-Nitrosylation
ca Caspase cleavage
sc Succinylation

Overview
ITGAV The alpha-V integrins are receptors for vitronectin, cytotactin, fibronectin, fibrinogen, laminin, matrix metalloproteinase-2, osteopontin, osteomodulin, prothrombin, thrombospondin and vWF. They recognize the sequence R-G-D in a wide array of ligands. In case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions. Belongs to the integrin alpha chain family. 2 isoforms of the human protein are produced by alternative splicing. Note: This description may include information from UniProtKB.
Protein type: Membrane protein, integral; Motility/polarity/chemotaxis; Cell adhesion
Chromosomal Location of Human Ortholog: 2q31-q32
Cellular Component: cell surface; filopodium membrane; focal adhesion; integrin complex; membrane; microvillus membrane; phagocytic vesicle; plasma membrane
Molecular Function: C-X3-C chemokine binding; coreceptor activity; extracellular matrix binding; fibroblast growth factor binding; fibronectin binding; insulin-like growth factor I binding; opsonin binding; protease binding; protein binding; protein kinase C binding; transforming growth factor beta binding; voltage-gated calcium channel activity
Biological Process: angiogenesis; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; cell adhesion; cell growth; cell migration; cell-matrix adhesion; cell-substrate adhesion; entry of virus into host cell; extracellular matrix organization and biogenesis; heterotypic cell-cell adhesion; leukocyte migration; negative chemotaxis; negative regulation of lipid transport; negative regulation of lipoprotein metabolic process; negative regulation of low-density lipoprotein receptor biosynthetic process; positive regulation of cell adhesion; positive regulation of cell proliferation; regulation of phagocytosis; vascular endothelial growth factor receptor signaling pathway
Reference #:  P06756 (UniProtKB)
Alt. Names/Synonyms: antigen identified by monoclonal antibody L230; CD51; DKFZp686A08142; Integrin alpha-V; Integrin alpha-V heavy chain; Integrin alpha-V light chain; integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51); ITAV; ITGAV; MSK8; Vitronectin receptor subunit alpha; VNRA
Gene Symbols: ITGAV
Molecular weight: 116,038 Da
Basal Isoelectric point: 5.45  Predict pI for various phosphorylation states
CST Pathways:  Actin Dynamics  |  GPCR Signaling to MAPKs  |  Growth And Differentiation Control by MAPKs  |  PI3K/Akt Signaling
Protein-Specific Antibodies or siRNAs from Cell Signaling Technology® Total Proteins
Select Structure to View Below

ITGAV

Protein Structure Not Found.
Download PyMol Script
Download ChimeraX Script


STRING  |  cBioPortal  |  Wikipedia  |  Reactome  |  neXtProt  |  Protein Atlas  |  BioGPS  |  Scansite  |  Pfam  |  RCSB PDB  |  Phospho3D  |  Phospho.ELM  |  NetworKIN  |  GeneCards  |  UniProtKB  |  Entrez-Gene  |  Ensembl Gene  |  Ensembl Protein


Modification Sites and Domains Show Modification Legend
Click here to view phosphorylation modifications only

Modification Sites in Parent Protein, Orthologs, and Isoforms Show Modification Legend
 

Show Multiple Sequence Alignment



 LTP 

LTP: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


 HTP 

HTP: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


       human

 
0 1 S21‑p RGLPLLLsGLLLPLC
0 1 K149‑sm YHWRTEMkQEREPVG
0 2 K233‑ub DPNVYSIkYNNQLAT
0 1 T279‑p GVPRAARtLGMVyIY
0 1 Y284‑p ARtLGMVyIYDGKNM
0 2 K360‑ub SGDFQTTkLNGFEVF
0 1 K399‑ub APYGGEDkKGIVyIF
0 1 Y404‑p EDkKGIVyIFNGRST
0 1 K446‑ub KGATDIDkNGYPDLI
0 1 K581‑ub DESEFRDkLTPItIF
0 1 T586‑p RDkLTPItIFMEyRL
0 1 Y591‑p PItIFMEyRLDYRTA
0 1 K645‑ub VSVDSDQkKIYIGDD
0 1 S749‑p KFDLQIQsSNLFDKV
0 1 T798‑p EHKENPEtEEDVGPV
0 1 S866‑p NPLRIKIsSLQTTEk
0 1 K873‑ub sSLQTTEkNDTVAGQ
0 8 S1046‑p HENGEGNsEt_____
0 3 T1048‑p NGEGNsEt_______
  mouse

 
P21 GGLLLLLPGLLLPLA
K149 YHWRTEMKQEREPVG
K233 DPNVYSIKYNNQLAT
T279 GVPRAARTLGMVYIY
Y284 ARTLGMVYIYDGKNM
K360 VGDFQTTKLNGFEVF
K399 APYGGEDKKGLVYIF
Y404 EDKKGLVYIFNGRST
R446 KGATDVDRNGYPDLV
K581 DESEFRDKLTPITIF
T586 RDKLTPITIFMEYRL
Y591 PITIFMEYRLDQRTA
K645 VSVNSDQKKIYIGDD
S749 KFDLKIQSSNSFDNV
T798 EYKENPETEEDVGPI
- gap
K868 LRIKTPEKNDTAAAG
S1042‑p HENGEGNsEt_____
T1044‑p NGEGNsEt_______
  rat

 
L21 GGLLLLLLGLLLPFA
K149 YHWRTEMKQEREPVG
K233 DPNVYSIKYNNQLAT
T279 GVPRAARTLGMVYIY
Y284 ARTLGMVYIYDGKNM
K360 SGDFQTTKLNGFEVF
K399 APYGGEDKKGLVYIF
Y404 EDKKGLVYIFNGRST
R446 KGATDVDRNGYPDLV
Y580 PISKGRVYSCQMDVR
D585 RVYSCQMDVRRGYIV
Y590 QMDVRRGYIVKKPIS
K644 VSVDSDQKKIYIGDD
S748 KFDLKIQSSNSFDNV
T797 EYKETPETEEDVGPV
- gap
K867 LRIKTPEKNDTAAEQ
S1040‑p HENGEGNsET_____
T1042 NGEGNsET_______
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.